Cargando…
Antiviral therapy in acute viral hepatitis B: why and when
Acute viral hepatitis B is cleared in more than 95% of patients, while the remainder ones may develop either chronic HBV infection or, rarely, fulminant hepatitis. Therefore there are elderly patients with severe acute HBV hepatitis caractherized by high serum bilirubin levels >15 mmole/dl, inter...
Autores principales: | Morelli, Giuseppe, Perrella, Alessandro, Sbreglia, Costanza, Bellopede, Pasquale, Riccio, Vincenzo, Perrella, Oreste |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2640373/ https://www.ncbi.nlm.nih.gov/pubmed/19149879 http://dx.doi.org/10.1186/1750-9378-4-2 |
Ejemplares similares
-
Antiviral therapy in acute viral hepatitis B: why and when
por: Morelli, Giuseppe, et al.
Publicado: (2009) -
Safety of new DAAs for chronic HCV infection in a real life experience: role of a surveillance network based on clinician and hospital pharmacist
por: Nappi, A., et al.
Publicado: (2017) -
Antiviral Drugs for Viral Pneumonia
por: Bansal, Tapesh
Publicado: (2023) -
Why, When and How to Adjust Your P Values?
por: Jafari, Mohieddin, et al.
Publicado: (2019) -
Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy
por: Buonaguro, Luigi, et al.
Publicado: (2008)